Effectiveness of dental local analgesia among children for dental extractions
Effectiveness of 4% Articaine with 1:100,000 adrenaline in achieving local analgesia through buccal infiltration for dental extraction in the upper jaw among children.
Dental Health Services Western Australia
50 participants
Mar 2, 2010
Interventional
Conditions
Summary
The aim of the study is to determine if adequate local analgesia can be obtained to undertake dental extractions of permanent teeth in the upper jaw among children by buccal administration of local analgesia only without the need for palatal administration of local analgesia.
Eligibility
Inclusion Criteria1
- Child registered with Dental Health Services WA. Child requires bilateral maxillary permanent teeth requiring extractions as part of orthodontic treatment as requested by specialist orthodontist
Exclusion Criteria10
- There must be no:
- a. History of allergy to local anaesthetic or any of its constituents.
- b. Medical conditions contraindicating the use of local analgesia or to undergo dental treatment under local analgesia.
- c. medications being taken likely to interfere with reporting of pain (analgesics).
- d. Neurological disorders with sensory disturbances or communication difficulties.
- e. Non-cooperative behaviour for dental treatment under local analgesia.
- f. Difficulty with communicating effectively in the English language.
- g. Possibility of pregnancy.
- h. Evidence of soft tissue infection/inflammation near site of injection.
- i. body weight below 30 kg.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Comparison of the effectiveness of 4% Articaine with 1:100,000 adrenaline compared with Lignocaine 2% with 1:100,000 adrenaline in achieving local analgesia for dental extractions in the upper jaw among children when delivered as buccal infiltration only adjacent to the tooth to be extracted. Dosage of local anaesthetic limited to 5mg/kg body weight, to a maximum of 2.2ml cartridge of local anaesthetic. Supplementation with Lignocaine 2% permitted for palatal analgesia, dosage not to exceed 5mg/kg body weight. Mode of administration: buccal infiltration injection. Type of anaesthetic used (test or control) for one side of the mouth determined by random allocation.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610000889055